MedPath

Cough Out

Cough Out

Approved
Approval ID

fe4c3921-8d30-4cd6-ba90-9211b362a38a

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Jun 18, 2025

Manufacturers
FDA

Efficient Laboratories Inc.

DUNS: 969044932

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Guaifenesin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code58593-255
Application NumberM012
Product Classification
M
Marketing Category
C200263
G
Generic Name
Guaifenesin
Product Specifications
Route of AdministrationORAL
Effective DateJune 18, 2025
FDA Product Classification

INGREDIENTS (10)

ALOE VERA LEAFInactive
Code: ZY81Z83H0X
Classification: IACT
HONEYInactive
Code: Y9H1V576FH
Classification: IACT
MENTHOLInactive
Code: L7T10EIP3A
Classification: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ASPARTAMEInactive
Code: Z0H242BBR1
Classification: IACT
GUAIFENESINActive
Quantity: 100 mg in 5 mL
Code: 495W7451VQ
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 2/15/2020

CoughOutLabel

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 2/15/2020

**Uses**

Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 2/15/2020

Active Ingredient: (In each teaspoonful 5 mls) Purpose

Guiafenesin 100 mg (USP)............................................Expectorant

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 2/15/2020

PurposeExpectorant

WARNINGS SECTION

LOINC: 34071-1Updated: 2/15/2020

Warnings

**Do not exceed recommended dosage**

**Ask a doctor before use if you have**

  • a cough that is accompanied by excessive phlegm (mucus)
  • a persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema.

**Stop use and ask a doctor if**

  • cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persstent headached. A persistent cough may be a sign of a serious condition.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 2/15/2020

Keep Out of Reach of Children.

In case of accidental overdose, get medical help or contact the Poison Control Center right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

LOINC: 53414-9Updated: 2/15/2020

**If pregnant or breast-feeding,**ask a health professional before use.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 2/15/2020

Directions:

Shake well immediately before use.

Do not exceed 6 doses in any 24 hour period.

Adults and Children 12 years and over - 10 ml (2 tsps) every 4 hours

Children 6 to under 12 years of age - 5 ml (1 tsp) every 4 hours

Children under 6 years of age - Do not use

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 2/15/2020

**Inactive Ingredients:**Aloe Vera, Aspartame, Honey, Menthol, Methylparaben, Potassium Sorbate, Propylene Glycol, Propylparaben, Purified Water

OTHER SAFETY INFORMATION

LOINC: 60561-8Updated: 2/15/2020

Each 5 mls contains: sodium 5 mg, and potassium 5 mg

Phenylketonurics: Contains Phenylalanine 2.5 mg per 5 ml (teaspoonful).

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 2/15/2020

Questions or Comments?

305.805.3456 Monday-Friday 9AM to 5PM EST

www.efficientlabs.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cough Out - FDA Drug Approval Details